GILEAD SCIENCES, INC. - Common Stock (GILD)

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock
Shares outstanding
1,240,722,841
Number of holders
1,868
Total 13F shares, excl. options
1,061,928,121
Shares change
+16,830,352
Total reported value, excl. options
$98,045,307,663
Value change
+$1,597,585,192
Put/Call ratio
109%
Number of buys
796
Number of sells
-811
Price
$92.37

Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q4 2024

2,042 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q4 2024.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,868 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,061,928,121 shares of 1,240,722,841 outstanding shares and own 86% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (120,355,841 shares), VANGUARD GROUP INC (115,528,392 shares), Capital World Investors (71,706,362 shares), STATE STREET CORP (60,381,755 shares), Capital Research Global Investors (57,946,228 shares), FMR LLC (40,319,432 shares), WELLINGTON MANAGEMENT GROUP LLP (35,659,007 shares), Dodge & Cox (32,947,717 shares), GEODE CAPITAL MANAGEMENT, LLC (28,289,917 shares), and MORGAN STANLEY (20,070,463 shares).
This table shows the top 1,868 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.